nodes	percent_of_prediction	percent_of_DWPC	metapath
Metyrapone—ABCC3—Fluorouracil—head and neck cancer	0.569	0.627	CbGbCtD
Metyrapone—CYP2A6—Fluorouracil—head and neck cancer	0.252	0.278	CbGbCtD
Metyrapone—CYP3A4—Vinblastine—head and neck cancer	0.0468	0.0516	CbGbCtD
Metyrapone—CYP3A4—Docetaxel—head and neck cancer	0.0385	0.0425	CbGbCtD
Metyrapone—ABCC3—Fluoropyrimidine Activity—XRCC3—head and neck cancer	0.00412	0.0536	CbGpPWpGaD
Metyrapone—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00279	0.0362	CbGpPWpGaD
Metyrapone—ABCC3—Fluoropyrimidine Activity—DPYD—head and neck cancer	0.00274	0.0356	CbGpPWpGaD
Metyrapone—CYP2A6—Fluoropyrimidine Activity—XRCC3—head and neck cancer	0.00258	0.0335	CbGpPWpGaD
Metyrapone—ABCC3—Fluoropyrimidine Activity—SMUG1—head and neck cancer	0.00195	0.0253	CbGpPWpGaD
Metyrapone—CYP2A6—Fluoropyrimidine Activity—DPYD—head and neck cancer	0.00171	0.0223	CbGpPWpGaD
Metyrapone—Bone marrow depression—Hydroxyurea—head and neck cancer	0.00168	0.0996	CcSEcCtD
Metyrapone—CYP2A6—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.00163	0.0212	CbGpPWpGaD
Metyrapone—ABCC3—Fluoropyrimidine Activity—TYMS—head and neck cancer	0.00156	0.0203	CbGpPWpGaD
Metyrapone—CYP11B2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00146	0.019	CbGpPWpGaD
Metyrapone—CYP11B2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00144	0.0187	CbGpPWpGaD
Metyrapone—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00138	0.0179	CbGpPWpGaD
Metyrapone—CYP2A6—Xenobiotics—CYP1A1—head and neck cancer	0.00137	0.0178	CbGpPWpGaD
Metyrapone—CYP11B2—Biological oxidations—NAT2—head and neck cancer	0.00134	0.0175	CbGpPWpGaD
Metyrapone—CYP11B2—Metapathway biotransformation—NAT2—head and neck cancer	0.00132	0.0172	CbGpPWpGaD
Metyrapone—CYP2A6—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00131	0.0171	CbGpPWpGaD
Metyrapone—CYP2E1—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.00129	0.0168	CbGpPWpGaD
Metyrapone—CYP11B1—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00126	0.0164	CbGpPWpGaD
Metyrapone—CYP11B1—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00124	0.0161	CbGpPWpGaD
Metyrapone—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.00122	0.0159	CbGpPWpGaD
Metyrapone—CYP2A6—Fluoropyrimidine Activity—SMUG1—head and neck cancer	0.00122	0.0159	CbGpPWpGaD
Metyrapone—CYP11B2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00118	0.0154	CbGpPWpGaD
Metyrapone—CYP11B1—Biological oxidations—NAT2—head and neck cancer	0.00116	0.015	CbGpPWpGaD
Metyrapone—CYP2E1—Vitamin A and Carotenoid Metabolism—RARB—head and neck cancer	0.00114	0.0149	CbGpPWpGaD
Metyrapone—CYP11B1—Metapathway biotransformation—NAT2—head and neck cancer	0.00114	0.0148	CbGpPWpGaD
Metyrapone—CYP2E1—Xenobiotics—CYP1A1—head and neck cancer	0.00108	0.014	CbGpPWpGaD
Metyrapone—CYP2E1—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00104	0.0135	CbGpPWpGaD
Metyrapone—CYP11B1—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00102	0.0133	CbGpPWpGaD
Metyrapone—CYP2A6—Fluoropyrimidine Activity—TYMS—head and neck cancer	0.000976	0.0127	CbGpPWpGaD
Metyrapone—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—head and neck cancer	0.000971	0.0126	CbGpPWpGaD
Metyrapone—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.000948	0.0123	CbGpPWpGaD
Metyrapone—ABCC3—NRF2 pathway—TGFA—head and neck cancer	0.000807	0.0105	CbGpPWpGaD
Metyrapone—Dermatitis atopic—Docetaxel—head and neck cancer	0.000795	0.0472	CcSEcCtD
Metyrapone—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—head and neck cancer	0.000765	0.00995	CbGpPWpGaD
Metyrapone—Pancytopenia—Vinblastine—head and neck cancer	0.00074	0.0439	CcSEcCtD
Metyrapone—Pancytopenia—Hydroxyurea—head and neck cancer	0.000675	0.0401	CcSEcCtD
Metyrapone—CYP11B2—Biological oxidations—GSTM1—head and neck cancer	0.000663	0.00862	CbGpPWpGaD
Metyrapone—CYP11B2—Metapathway biotransformation—GSTM1—head and neck cancer	0.000654	0.0085	CbGpPWpGaD
Metyrapone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00064	0.00832	CbGpPWpGaD
Metyrapone—CYP11B2—Biological oxidations—CYP1A1—head and neck cancer	0.000628	0.00817	CbGpPWpGaD
Metyrapone—CYP11B2—Metapathway biotransformation—CYP1A1—head and neck cancer	0.00062	0.00806	CbGpPWpGaD
Metyrapone—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000599	0.00779	CbGpPWpGaD
Metyrapone—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000575	0.00748	CbGpPWpGaD
Metyrapone—CYP11B1—Biological oxidations—GSTM1—head and neck cancer	0.000571	0.00743	CbGpPWpGaD
Metyrapone—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000567	0.00738	CbGpPWpGaD
Metyrapone—CYP11B1—Metapathway biotransformation—GSTM1—head and neck cancer	0.000563	0.00733	CbGpPWpGaD
Metyrapone—CYP2A6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00056	0.00728	CbGpPWpGaD
Metyrapone—CYP11B1—Corticotropin-releasing hormone—BCL2—head and neck cancer	0.000559	0.00727	CbGpPWpGaD
Metyrapone—CYP2E1—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000554	0.00721	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—UROD—head and neck cancer	0.000553	0.00719	CbGpPWpGaD
Metyrapone—Alopecia—Vinblastine—head and neck cancer	0.000551	0.0327	CcSEcCtD
Metyrapone—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000545	0.00709	CbGpPWpGaD
Metyrapone—CYP11B1—Biological oxidations—CYP1A1—head and neck cancer	0.000541	0.00704	CbGpPWpGaD
Metyrapone—CYP11B1—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000534	0.00695	CbGpPWpGaD
Metyrapone—CYP2A6—Biological oxidations—NAT2—head and neck cancer	0.000522	0.00679	CbGpPWpGaD
Metyrapone—ABCC3—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000517	0.00673	CbGpPWpGaD
Metyrapone—Angiopathy—Hydroxyurea—head and neck cancer	0.000516	0.0306	CcSEcCtD
Metyrapone—CYP2A6—NRF2 pathway—TGFA—head and neck cancer	0.000506	0.00658	CbGpPWpGaD
Metyrapone—Alopecia—Hydroxyurea—head and neck cancer	0.000503	0.0298	CcSEcCtD
Metyrapone—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000501	0.00651	CbGpPWpGaD
Metyrapone—CYP11B1—Corticotropin-releasing hormone—IL2—head and neck cancer	0.000492	0.0064	CbGpPWpGaD
Metyrapone—Pancytopenia—Fluorouracil—head and neck cancer	0.000486	0.0288	CcSEcCtD
Metyrapone—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000482	0.00627	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—UROD—head and neck cancer	0.000476	0.0062	CbGpPWpGaD
Metyrapone—Hypertension—Vinblastine—head and neck cancer	0.000469	0.0278	CcSEcCtD
Metyrapone—ABCC3—NRF2 pathway—GSTM1—head and neck cancer	0.000469	0.0061	CbGpPWpGaD
Metyrapone—CYP2A6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00046	0.00598	CbGpPWpGaD
Metyrapone—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000448	0.00583	CbGpPWpGaD
Metyrapone—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000442	0.00575	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000429	0.00558	CbGpPWpGaD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000419	0.0249	CcSEcCtD
Metyrapone—CYP2E1—Biological oxidations—NAT2—head and neck cancer	0.000412	0.00536	CbGpPWpGaD
Metyrapone—CYP2E1—Metapathway biotransformation—NAT2—head and neck cancer	0.000406	0.00529	CbGpPWpGaD
Metyrapone—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000397	0.0235	CcSEcCtD
Metyrapone—CYP11B1—Corticotropin-releasing hormone—MAPK3—head and neck cancer	0.000396	0.00515	CbGpPWpGaD
Metyrapone—Skin disorder—Hydroxyurea—head and neck cancer	0.000393	0.0233	CcSEcCtD
Metyrapone—ABCC3—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000385	0.005	CbGpPWpGaD
Metyrapone—Pain—Vinblastine—head and neck cancer	0.000379	0.0225	CcSEcCtD
Metyrapone—CYP11B1—Corticotropin-releasing hormone—MAPK1—head and neck cancer	0.000377	0.0049	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000369	0.00481	CbGpPWpGaD
Metyrapone—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000363	0.00473	CbGpPWpGaD
Metyrapone—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000363	0.0215	CcSEcCtD
Metyrapone—Alopecia—Fluorouracil—head and neck cancer	0.000362	0.0215	CcSEcCtD
Metyrapone—Pancytopenia—Docetaxel—head and neck cancer	0.000351	0.0208	CcSEcCtD
Metyrapone—Abdominal pain—Vinblastine—head and neck cancer	0.00035	0.0208	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000349	0.0207	CcSEcCtD
Metyrapone—Pain—Hydroxyurea—head and neck cancer	0.000346	0.0205	CcSEcCtD
Metyrapone—ABCC3—Metabolism—UROD—head and neck cancer	0.000343	0.00446	CbGpPWpGaD
Metyrapone—CYP2A6—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000324	0.00421	CbGpPWpGaD
Metyrapone—CYP2A6—NRF2 pathway—GSTM1—head and neck cancer	0.000294	0.00382	CbGpPWpGaD
Metyrapone—Dizziness—Vinblastine—head and neck cancer	0.000293	0.0174	CcSEcCtD
Metyrapone—Nervous system disorder—Fluorouracil—head and neck cancer	0.000285	0.0169	CcSEcCtD
Metyrapone—Vomiting—Vinblastine—head and neck cancer	0.000282	0.0167	CcSEcCtD
Metyrapone—Headache—Vinblastine—head and neck cancer	0.000278	0.0165	CcSEcCtD
Metyrapone—Hypotension—Fluorouracil—head and neck cancer	0.000272	0.0161	CcSEcCtD
Metyrapone—Angiopathy—Docetaxel—head and neck cancer	0.000268	0.0159	CcSEcCtD
Metyrapone—Dizziness—Hydroxyurea—head and neck cancer	0.000267	0.0159	CcSEcCtD
Metyrapone—CYP11B1—Corticotropin-releasing hormone—AKT1—head and neck cancer	0.000267	0.00347	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000266	0.00346	CbGpPWpGaD
Metyrapone—Nausea—Vinblastine—head and neck cancer	0.000263	0.0156	CcSEcCtD
Metyrapone—Alopecia—Docetaxel—head and neck cancer	0.000261	0.0155	CcSEcCtD
Metyrapone—CYP2A6—Biological oxidations—GSTM1—head and neck cancer	0.000258	0.00335	CbGpPWpGaD
Metyrapone—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000257	0.00335	CbGpPWpGaD
Metyrapone—Vomiting—Hydroxyurea—head and neck cancer	0.000257	0.0153	CcSEcCtD
Metyrapone—Headache—Hydroxyurea—head and neck cancer	0.000253	0.015	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000251	0.0149	CcSEcCtD
Metyrapone—Pain—Fluorouracil—head and neck cancer	0.000249	0.0148	CcSEcCtD
Metyrapone—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—head and neck cancer	0.000247	0.00321	CbGpPWpGaD
Metyrapone—CYP2A6—Biological oxidations—CYP1A1—head and neck cancer	0.000244	0.00318	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000244	0.00317	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000241	0.00314	CbGpPWpGaD
Metyrapone—Nausea—Hydroxyurea—head and neck cancer	0.00024	0.0143	CcSEcCtD
Metyrapone—CYP11B2—Metabolism—NAT2—head and neck cancer	0.000229	0.00299	CbGpPWpGaD
Metyrapone—Hypertension—Docetaxel—head and neck cancer	0.000222	0.0132	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000218	0.0129	CcSEcCtD
Metyrapone—CYP2A6—Metabolism—UROD—head and neck cancer	0.000215	0.00279	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.00021	0.00273	CbGpPWpGaD
Metyrapone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000208	0.00271	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000208	0.0027	CbGpPWpGaD
Metyrapone—Nervous system disorder—Docetaxel—head and neck cancer	0.000206	0.0122	CcSEcCtD
Metyrapone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000205	0.00267	CbGpPWpGaD
Metyrapone—Skin disorder—Docetaxel—head and neck cancer	0.000204	0.0121	CcSEcCtD
Metyrapone—CYP2E1—Biological oxidations—GSTM1—head and neck cancer	0.000204	0.00265	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—DPYD—head and neck cancer	0.000201	0.00262	CbGpPWpGaD
Metyrapone—CYP2E1—Metapathway biotransformation—GSTM1—head and neck cancer	0.000201	0.00261	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—NAT2—head and neck cancer	0.000198	0.00257	CbGpPWpGaD
Metyrapone—Hypotension—Docetaxel—head and neck cancer	0.000196	0.0116	CcSEcCtD
Metyrapone—CYP2E1—Biological oxidations—CYP1A1—head and neck cancer	0.000193	0.00251	CbGpPWpGaD
Metyrapone—Dizziness—Fluorouracil—head and neck cancer	0.000192	0.0114	CcSEcCtD
Metyrapone—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000191	0.00249	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—YAP1—head and neck cancer	0.000191	0.00248	CbGpPWpGaD
Metyrapone—CYP2E1—Metapathway biotransformation—CYP1A1—head and neck cancer	0.00019	0.00248	CbGpPWpGaD
Metyrapone—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000189	0.00245	CbGpPWpGaD
Metyrapone—Vomiting—Fluorouracil—head and neck cancer	0.000185	0.011	CcSEcCtD
Metyrapone—Headache—Fluorouracil—head and neck cancer	0.000182	0.0108	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000181	0.0108	CcSEcCtD
Metyrapone—Pain—Docetaxel—head and neck cancer	0.00018	0.0107	CcSEcCtD
Metyrapone—CYP11B1—Metabolism—DPYD—head and neck cancer	0.000173	0.00226	CbGpPWpGaD
Metyrapone—Nausea—Fluorouracil—head and neck cancer	0.000173	0.0103	CcSEcCtD
Metyrapone—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000172	0.0102	CcSEcCtD
Metyrapone—CYP2E1—Metabolism—UROD—head and neck cancer	0.00017	0.00221	CbGpPWpGaD
Metyrapone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000169	0.00219	CbGpPWpGaD
Metyrapone—Abdominal pain—Docetaxel—head and neck cancer	0.000166	0.00985	CcSEcCtD
Metyrapone—CYP11B1—Metabolism—YAP1—head and neck cancer	0.000165	0.00214	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000151	0.00197	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.00015	0.00195	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000143	0.00187	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—NAT2—head and neck cancer	0.000142	0.00185	CbGpPWpGaD
Metyrapone—Dizziness—Docetaxel—head and neck cancer	0.000139	0.00824	CcSEcCtD
Metyrapone—Vomiting—Docetaxel—head and neck cancer	0.000134	0.00793	CcSEcCtD
Metyrapone—Headache—Docetaxel—head and neck cancer	0.000132	0.00781	CcSEcCtD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000125	0.00163	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—DPYD—head and neck cancer	0.000125	0.00162	CbGpPWpGaD
Metyrapone—Nausea—Docetaxel—head and neck cancer	0.000125	0.0074	CcSEcCtD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000124	0.00161	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—YAP1—head and neck cancer	0.000118	0.00154	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—TYMS—head and neck cancer	0.000115	0.00149	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—GSTM1—head and neck cancer	0.000113	0.00147	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—GPX1—head and neck cancer	0.000109	0.00141	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000108	0.0014	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—CYP1A1—head and neck cancer	0.000107	0.0014	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—TYMS—head and neck cancer	9.88e-05	0.00129	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—GSTM1—head and neck cancer	9.77e-05	0.00127	CbGpPWpGaD
Metyrapone—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	9.44e-05	0.00123	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—GPX1—head and neck cancer	9.35e-05	0.00122	CbGpPWpGaD
Metyrapone—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	9.31e-05	0.00121	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—CYP1A1—head and neck cancer	9.26e-05	0.0012	CbGpPWpGaD
Metyrapone—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	8.95e-05	0.00116	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—NAT2—head and neck cancer	8.92e-05	0.00116	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	8.9e-05	0.00116	CbGpPWpGaD
Metyrapone—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	8.83e-05	0.00115	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	8.83e-05	0.00115	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—UROD—head and neck cancer	7.88e-05	0.00102	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—DPYD—head and neck cancer	7.82e-05	0.00102	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	7.76e-05	0.00101	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	7.61e-05	0.00099	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—YAP1—head and neck cancer	7.42e-05	0.000966	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—TYMS—head and neck cancer	7.11e-05	0.000926	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—NAT2—head and neck cancer	7.05e-05	0.000917	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—GSTM1—head and neck cancer	7.03e-05	0.000915	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—GPX1—head and neck cancer	6.73e-05	0.000876	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CYP1A1—head and neck cancer	6.67e-05	0.000867	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PTGS2—head and neck cancer	6.39e-05	0.000831	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—DPYD—head and neck cancer	6.18e-05	0.000804	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—YAP1—head and neck cancer	5.86e-05	0.000763	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PTEN—head and neck cancer	5.57e-05	0.000725	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PTGS2—head and neck cancer	5.51e-05	0.000716	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.48e-05	0.000713	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PTEN—head and neck cancer	4.8e-05	0.000625	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—TYMS—head and neck cancer	4.46e-05	0.00058	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GSTM1—head and neck cancer	4.41e-05	0.000573	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GPX1—head and neck cancer	4.22e-05	0.000549	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CYP1A1—head and neck cancer	4.18e-05	0.000543	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PTGS2—head and neck cancer	3.96e-05	0.000516	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PIK3CA—head and neck cancer	3.93e-05	0.000511	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—TYMS—head and neck cancer	3.52e-05	0.000458	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GSTM1—head and neck cancer	3.48e-05	0.000453	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PTEN—head and neck cancer	3.46e-05	0.00045	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PIK3CA—head and neck cancer	3.39e-05	0.000441	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GPX1—head and neck cancer	3.33e-05	0.000434	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CYP1A1—head and neck cancer	3.3e-05	0.000429	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—NAT2—head and neck cancer	3.27e-05	0.000425	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—AKT1—head and neck cancer	3.21e-05	0.000418	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—DPYD—head and neck cancer	2.87e-05	0.000373	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—AKT1—head and neck cancer	2.77e-05	0.00036	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—YAP1—head and neck cancer	2.72e-05	0.000354	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PTGS2—head and neck cancer	2.48e-05	0.000323	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PIK3CA—head and neck cancer	2.44e-05	0.000317	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PTEN—head and neck cancer	2.17e-05	0.000282	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—AKT1—head and neck cancer	1.99e-05	0.000259	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PTGS2—head and neck cancer	1.96e-05	0.000255	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PTEN—head and neck cancer	1.71e-05	0.000223	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—TYMS—head and neck cancer	1.63e-05	0.000213	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.62e-05	0.00021	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GPX1—head and neck cancer	1.55e-05	0.000201	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.53e-05	0.000199	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PIK3CA—head and neck cancer	1.53e-05	0.000199	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—AKT1—head and neck cancer	1.25e-05	0.000162	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PIK3CA—head and neck cancer	1.21e-05	0.000157	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—AKT1—head and neck cancer	9.86e-06	0.000128	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PTGS2—head and neck cancer	9.11e-06	0.000118	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PTEN—head and neck cancer	7.94e-06	0.000103	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PIK3CA—head and neck cancer	5.6e-06	7.29e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—AKT1—head and neck cancer	4.58e-06	5.95e-05	CbGpPWpGaD
